Appointment

VENUS 6nioy g nnoua! iolls VRLJSEC/EXC HAl\lG E Date : 20. 08. 2026 National Stock Exchange Of India Ltd. BSE Limited 5th Floor, Exchange Plaza 25th Floor, Phiroze Jeejeebhoy Bandra (E), Towers, Dalal Street Mumbai-400 051 Mumbai Script Code: VENUSREM Script Code: 526953 Sub.: Disclosure under Regulation 30 Of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/ Madam, ln continuation to the disclosures made on 26th May 2026 by the Company to the Stock Exchanges regarding the approval Of the Board Of Directors for the proposed appointment/re-appointment Of Directors, the Company hereby informs that the fallowing matters were placed before the Members at the 37th Annual General Meeting Of the Company held on August 20, 2026: i.Appointment Of Mr. Saransh Chaudhary (DIN: 08752105) as an Executive Director (Whole lime Director) for a period Of 5 (five) consecutive years starting from 26th May 2026. ii.Appointment Of Dr. Gurminder Singh Bedi (DIN: 11713102) as a Nan-Executive Independent Director for a period Of 5 (five) consecutive years starting from 26th May 2026. iti.Re-appointment Of Dr. (Mrs.) Manu Chaudhary (DIN: 00435834) as Joint Managing Director for the period Of five years w.e.f. 1 st October 2026. iv.Re-appointment Of Dr. Mrs.) Savita Gupta (DIN: 0009450913) as Non-Executive Independent Director for 2nd term Of five years w.e.f. 29Ch December 2026. The aforesaid matters were considered by the Members at the Annual General Meeting. The voting results Of the resolutions, along wth the Scrutiniser`s Report, will be submitted to the Stock Exchanges within the prescribed timelines upon completion and consolidation Of the voting process. The disclosure is being made in continuation Of the earlier disclosures made by the Company in this regard. Vvith roferenoe to above mentioned appointments/re-appointments the details as required under the regulation 30 Of SEBI LODR, are annexed as `Annexure' This intimation is also being uploaded on the Company's website at httDSMivww.venusremedies.com Thanking you. Yours faithfully, for VENUS REMEDIES LllvIITED Neha (Company Secretary) M. No. F8374 VENUS REMEDIES LIMITED Corpor.te omc® : Uult-I : 51-52, Industrial Area, Phase-I, Panchkula (Hry.) i:,-.5.2+5Tf,u7S!=2a!3A3r686?29Se3-6,9Z?nFcft+ls|(F|72'-!3:5!,36'ndla 134113, India R.8d. Office : Uult-II : SCO 857, Cabin No. 10, 2nd Floor, NAC, Manimajra, EEL?oolp#aun:tgidg,sifit:,.,Jr7a3TFoa5TIE:llap,Phase-IIfxtn) Chandigarh (U.T.) 160101, India Tel : +91-1792-242100` 242101 Website : www.venusremedies corn Ualt-V : www.vmrcindia com elTiail : infof«venusremedies com VENUS PHARMA GmbH ©#NErefur tEh F AM Bahnhof I-3, D-59368, CIN No, ` L24232CH 1989PLC009705 Werne. Gemany DIAN CUSTOMS e turf Partlcular8 Dr. (Mrs.) Manu Dr. (Ivlrs.) Savlfa Gupta Mr. Saran8h Dr. Gurmlnder Slngh Chaudharv Chaudliarv Bodl Reason for Change Re-appoi ntment for Re-appointment for 2nd term Appointment for the Appointment for the further period Of 5 of 5 Years as Nan Executive period of 5 Years as an period of 5 Years as an Years as Joint I ndependent Di rectors Additional Director Additional Director (Nan- Managlng Dlrector unole time Director) Executive I ndependentDirector) Date & Term of The reappointment will The reappointment will be Appoi nted as an Appointed as a Non- appointment be effective from lot effective from 30tt` Executive Director for a Executive Independent October 2026. December 2026. period of five consecutive Director for a period of five years with effect from consecutive years with 26th May 2026. effect from 26th May 2026. Brief Profile and Date of Dr. Chaudhary heads Dr. Savita Gupta ls Mr. Saransh Chaudhary, An experienced Birth(DOB) the R&D and opera- B.Tech, Master of an alumnus of the Orthopaedic Surgeon tions of the Company. Engineering and Ph.D. University of Oxford, has with over 33 years of post- She is M.Sc., M. Phil She has a rich been associated with MS experience. (Genetics) & Ph.D. She Experience of more than 35 Venus Remedies Limited Com pleted senior also enjoys more than years. for over 10 years and re8idency at three decades of expe- Currently she is currently serves as CEO Postgraduate Institute of rience in pharma. She working as Professor at of Venus Medicine Medlcal Education and designed and commis- UIET, Panjab Research Centre Research. Academically sioned the company's university, Chandigarh OVMRC) and President - distinguished with a Gold world- class manufac- and also served as Global Critical Care and Medal in MBBS and turlng facility at Baddi director at UIET, Panjab Consilmer Healthcare. recipient of the Pfizer in India. She helped University, He leads the Company's Gold Medal for excellence broaden the product Chandigarh. work in antimicrobial i n academ ics. Has portfolio, created a pro- DOB.18.08.1973 resistance, translation8l presented papers at ficient team and en- research, and consumer national conferences and riched company's intel- health, and has authored authored several national iectual property.DOB:26.12.1969 over 18 peer-reviewed a nd international research papers, publications in the field of including initiatives such orthopaedics. . as the establishment ofIndia'§firstOngan®n~a-Chiplaboratory.DOB:18.06.1995 DOB: 01.08.1967 Disclogure of She ig related to Mr. Not Related to any board He ig related to Mr. Not Related to any board relationship between the Paw8n Chaudhary, Mr. member of the Company Pawan Chaudhary, Mrs. member of the Company directors Akshansh Chaudhary, Manu Chaudhary, Mr. Mr. Saransh Akshansh Chaudhary, Chaudhary, M r. Mr. Peeyush Jain and Peeyush Jain and Mr.AshutoshJain Mr. Ashutosh Jain No. of shares held in theComoanv 15,68,000 Nil Nil N'I Information as requiredpursuanttoCircularofBSELimitedwithref.no.LIST/COMP/14/2018-19andCircularofStockIE:!'£an:!eofIndiaLimitedwithref.no.NSE/CML/2018/24,dated20thJune2018. Not Debarred Not Debarred Not Debarred Not Debarred